PhosphoAkt (research and development assay)

EPIC

PhosphoAkt by FACs

Section

Immunology

Clinical indications

Mutations in PIK3CD and PIK3R1 affect the PI3K signalling pathway and cause activated PI3kinase delta syndrome (APDS). This can cause hyperactivation of the pathway resulting in higher levels of phosphorylated Akt

Specimen requirement

5mls EDTA Plus a healthy control sample (10mls EDTA if the patient is lymphopenic)

Dispatch and handling instructions

This is a 2-day assay, please do not send on a Friday. Samples should be less than 48 hours old when received

Turnaround time

30 days

Synonym

Not applicable

Is it IS0 15189 accredited?

No (research)